DR.Chip Biotechnology Incorporation announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was TWD 23.495 million compared to TWD 9.916 million a year ago. Operating loss was TWD 5.082 million compared to TWD 7.517 million a year ago. Net loss was TWD 3.443 million compared to TWD 6.388 million a year ago. Basic loss per share was TWD 0.07 compared to TWD 0.13 a year ago. For the half year, total revenue was TWD 51.645 million compared to TWD 12.980 million a year ago. Operating loss was TWD 10.242 million compared to TWD 12.625 million a year ago. Net loss was TWD 6.936 million compared to TWD 11.446 million a year ago. Basic loss per share was TWD 0.14 compared to TWD 0.26 a year ago.